359 related articles for article (PubMed ID: 1615748)
1. [Immunologic phenotype of lymphocytes in chronic B-cell lymphocytic leukemia. I. B- and T-lymphocytes in chronic lymphocytic leukemia].
Rupniewska ZM; Wach M; Kowal M; Roliński J; Antosz H
Acta Haematol Pol; 1992; 23(1):21-7. PubMed ID: 1615748
[TBL] [Abstract][Full Text] [Related]
2. [Membrane characteristics of pathological clones of B-lymphocytes in patients with chronic lymphocytes leukemia (CLL)].
Pluta A
Pol Arch Med Wewn; 1989; 82(4-6):195-201. PubMed ID: 2642224
[No Abstract] [Full Text] [Related]
3. Altered constitutive and activation-induced expression of CD95 by B- and T-cells in B-cell chronic lymphocytic leukemia.
De Fanis U; Dalla Mora L; Romano C; Sellitto A; Tirelli A; Lucivero G
Haematologica; 2002 Mar; 87(3):325-7. PubMed ID: 11869948
[TBL] [Abstract][Full Text] [Related]
4. [Chronic lymphocytic leukemia. II. Differentiation of various forms of chronic lymphocytic leukemia by cytological and immunological indicators].
Popova L; Apostolov P; Vlaĭkova S; Stamenova L
Vutr Boles; 1988; 27(3):76-80. PubMed ID: 3264645
[TBL] [Abstract][Full Text] [Related]
5. In vitro activation of leukaemic B cells by interleukin-4 and antibodies to CD40.
Crawford DH; Catovsky D
Immunology; 1993 Sep; 80(1):40-4. PubMed ID: 7503945
[TBL] [Abstract][Full Text] [Related]
6. [Which cells in the differentiation process become precursors of B-cell chronic lymphoid leukemia?].
Rupniewska ZM; Rozynkowa D
Postepy Hig Med Dosw; 1988; 42(3):315-38. PubMed ID: 3073378
[No Abstract] [Full Text] [Related]
7. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
[TBL] [Abstract][Full Text] [Related]
8. Purine metabolism enzymes and immunological phenotype in chronic B-cell malignancies: chronic lymphocytic leukemia, prolymphocytic leukemia and hairy cell leukemia.
Babusíková O; Hrivnáková A; Klobusická M; Mesárosová A; Ujházy P
Neoplasma; 1990; 37(6):693-701. PubMed ID: 2125699
[TBL] [Abstract][Full Text] [Related]
9. B7 costimulatory molecules from malignant cells in patients with b-cell chronic lymphoproliferative disorders trigger t-cell proliferation.
Trentin L; Perin A; Siviero M; Piazza F; Facco M; Gurrieri C; Galvan S; Adami F; Agostini C; Pizzolo G; Zambello R; Semenzato G
Cancer; 2000 Sep; 89(6):1259-68. PubMed ID: 11002221
[TBL] [Abstract][Full Text] [Related]
10. [Immunosuppressor activity of B-cells in patients with chronic lymphocytic leukemia. Their possible role in the pathogenesis of the disease].
Chernykh ER; Tikhonova MA; Ostanin AA; Shevela EIa; Blazhievich IA; Shubinskiĭ GZ
Vestn Akad Med Nauk SSSR; 1991; (12):39-43. PubMed ID: 1801472
[TBL] [Abstract][Full Text] [Related]
11. Direct cellular interaction with activated CD4(+) T cells overcomes hyporesponsiveness of B-cell chronic lymphocytic leukemia in vitro.
Tretter T; Schuler M; Schneller F; Brass U; Esswein M; Aman MJ; Huber C; Peschel C
Cell Immunol; 1998 Oct; 189(1):41-50. PubMed ID: 9758693
[TBL] [Abstract][Full Text] [Related]
12. [Which cells during the process of differentiation give rise to chronic B-cell lymphocytic leukemia? I].
Rupniewska ZM; Rozynkowa D
Postepy Hig Med Dosw; 1988; 42(2):198-223. PubMed ID: 3076000
[No Abstract] [Full Text] [Related]
13. Surface markers of lymphocytes and immunoglobulin alterations in chronic lymphocytic leukemia (CLL).
Aydar S; Oğüt A; Undük H; Gündüz M
New Istanbul Contrib Clin Sci; 1978 Mar; 12(2):152-60. PubMed ID: 16302701
[No Abstract] [Full Text] [Related]
14. IL-13 has only a subset of IL-4-like activities on B chronic lymphocytic leukaemia cells.
Fluckiger AC; Brière F; Zurawski G; Bridon JM; Banchereau J
Immunology; 1994 Nov; 83(3):397-403. PubMed ID: 7530690
[TBL] [Abstract][Full Text] [Related]
15. Association studies of CTLA-4, CD28, and ICOS gene polymorphisms with B-cell chronic lymphocytic leukemia in the Polish population.
Suwalska K; Pawlak E; Karabon L; Tomkiewicz A; Dobosz T; Urbaniak-Kujda D; Kuliczkowski K; Wolowiec D; Jedynak A; Frydecka I
Hum Immunol; 2008 Mar; 69(3):193-201. PubMed ID: 18396212
[TBL] [Abstract][Full Text] [Related]
16. Direct or reverse correlations within the expression of activation, differentiation or T-B cooperation molecules on chronic lymphocytic leukemia B cells.
Sellitto A; De Fanis U; Romano C; Dalla Mora L; Guastafierro S; Tirelli A; Lucivero G
Minerva Med; 2003 Oct; 94(5):331-6, 336-9. PubMed ID: 14973427
[TBL] [Abstract][Full Text] [Related]
17. The biological and clinical relationship between CD5+23+ monoclonal B-cell lymphocytosis and chronic lymphocytic leukaemia.
Rawstron AC; Bennett F; Hillmen P
Br J Haematol; 2007 Dec; 139(5):724-9. PubMed ID: 18021087
[TBL] [Abstract][Full Text] [Related]
18. Impact of trisomy 12, del(13q), del(17p), and del(11q) on the immunophenotype, DNA ploidy status, and proliferative rate of leukemic B-cells in chronic lymphocytic leukemia.
Quijano S; López A; Rasillo A; Sayagués JM; Barrena S; Sánchez ML; Teodosio C; Giraldo P; Giralt M; Pérez MC; Romero M; Perdiguer L; Orfao A
Cytometry B Clin Cytom; 2008 May; 74(3):139-49. PubMed ID: 18061951
[TBL] [Abstract][Full Text] [Related]
19. Lymphotoxin beta expression is high in chronic lymphocytic leukemia but low in small lymphocytic lymphoma: a quantitative real-time reverse transcriptase polymerase chain reaction analysis.
Nagy B; Ferrer A; Larramendy ML; Galimberti S; Aalto Y; Casas S; Vilpo J; Ruutu T; Vettenranta K; Franssila K; Knuutila S
Haematologica; 2003 Jun; 88(6):654-8. PubMed ID: 12801841
[TBL] [Abstract][Full Text] [Related]
20. Clinical implication of chromosomal aberrations in chronic B-lymphocytic leukaemia cells.
Gahrton G; Juliusson G
Nouv Rev Fr Hematol (1978); 1988; 30(5-6):389-92. PubMed ID: 3265508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
